top of page
  • Ann Tucker

Upcoming FDA, SAMHSA Discussion on Naloxone Access

You are invited to participate in a stakeholder call to discuss naloxone access on November 28 at 2:30pm ET. Speakers will include FDA Commissioner Dr. Robert Califf and Marta Sokolowska, FDA Deputy Director for Substance Use and Behavioral Health. Dr. Miriam Delphin-Rittmon, SAMHSA Assistant Secretary for Mental Health and Substance Use, will also participate on the call. Read more

3 views0 comments

Recent Posts

See All

DEA [3/22] | In a public safety alert, the DEA said it observed a sharp increase in the trafficking of fentanyl mixed with xylazine, a sedative also known as “Tranq” that has been approved by the Food

bottom of page